Louis Samuels graduated Medical School from Hahnemann University (Philadelphia, PA) in 1987 and completed his Cardiothoracic Surgical training in 1995. He joined the faculty of Drexel University as the Surgical Director of Cardiac Transplantation. In 2001, Samuels and his team implanted the world’s 5th totally implantable electric artificial heart (AbioCor™). In 2003, he joined the Main Line Health System as the Surgical Director of Heart Failure. In addition to cardiac transplantation and LVAD implantation, Samuels performs CABG and Aortic Valve surgery. In 2012, Samuels became Professor of Surgery at Thomas Jefferson University School of Medicine.
Diabetes and Endocrinology
Yoshiaki Omura received both Oncology Residency Training and a Doctor of Science Degree through research on Pharmaco-Electro Physiology of Single Cardiac Cells in vivo and in vitro from Columbia University. He has published over 250 articles and 7 books. He is Executive Editor of Integrative Oncology & Editorial Board Member of Journal of Clinical Trials in Cardiology, etc. Using his new diagnostic method, which received U.S. patent, he can non-invasively and rapidly measure many neurotransmitters, other chemicals, asbestos, viruses, and bacteria. He developed non-invasive quick diagnostic methods of malignancies, as well as a method of evaluating the effects of any treatment.
Genetics of Cardiac Disease, Cardiac Biomarkers, Heart failure and Acute Coronary Syn
Aris Lacis, cardiac surgeon, professor, MD, PhD graduated Riga Medical Institute in 1961. General and thoracic surgeon in P. Stradina University Hospital in Riga (1964–1969). Thoracic and cardiac surgeon in the Latvian Centre for Cardiovascular Surgery (1969–1994). Since 1994 until 2012 – the head of Pediatric Cardiology and Cardiac Surgery Clinic in University Children’s Hospital, Riga; since 2012 – a consulting professor of this Clinic. President of Latvian Association for Pediatric Cardiologists. Author of 395 scientific publications, 3 monographs and 13 patents. Investigator in more than 10 clinical trials including cardiosurgical procedures performed under deep hypothermia, hybrid procedures etc. In may 2009 at first in the world have been used transcutan intramyocardial delivery autologous bone morrow derived progenitor stem cells for 3 months aged patient suffering from idiopathic dilated cardiomyopathy.In November 2010 the first patient with end stage pulmonary hypertension received intrapulmonary implantation autologous stem cells.
Cardiac Surgery, Pediatric Cardiology , Progenitor Stem Cells, Pulmonary Hypertension, Cardiomyopathy
Livia Valentin has completed her PhD from University of São Paulo School of Medicine- FMUSP and postdoctoral from Harvard Medical School; David Geffen School of Medicine at UCLA; Cleveland Clinic Lerner College of Medicine of Case Werstern University; University of Copenhagen; Utrecht University; Max Planck Institute and Karolinska Institute as a multicenter study. She is the Principal Investigator of the RCT Evaluation of POCD through the MentalPlus® digital game. She has published papers in anesthesia and neuropsychology journals and has been serving as an editorial board member of a indexed journal and reviewer of journal about anesthesiology and neuroscience.
Genetics of Cardiac Disease, Cardiac Biomarkers, Heart failure and Acute Coronary Syn
Fadlo Fraige Filho is a Full Professor of Endocrinology, Faculty of Medicine of ABC. He completed his PhD in Endocrinology, Faculty of Medicine from University of São Paulo, Brazil. He is a Member of the American Diabetes Association & Brazilian Society of Diabetes. He is currently the President of FENAD - National Federation of Associations and Entities of Diabetes and also of ANAD - National Association of Attention to Diabetes. He is the Head of the endocrinology sector of Hospital Beneficencia Portuguesa de São Paulo. He is the Editor-in-Chief of the Clinical Diabetes Journal.
Jagdish N. Sharma is currently a Professor in the Department of Pharmacology and Therapeutics of which he is the Founding Chairman, Faculty of Pharmacy, Kuwait University, Kuwait. He has also served as a Professor of Pharmacology at the Universiti Sains Malaysia, Penang, Malaysia, prior to joining Kuwait University in 1999. Prof. Sharma received his B.V.Sc. & A.H. (D.V.M.) in 1970 from Jawaharlal Nehru Agricultural University, Jabalpur, India; his M.Sc. in Medical Pharmacology in 1973 from the All-India Institute of Medical Sciences, New Delhi, India; and his Ph.D. in Pharmacology in1976 from the University of Strathclyde, Glasgow, Scotland, UK. The Calamus International University, London, U. K., in 2011, awarded D.Sc. degree in Health Sciences to Professor Sharma in recognition of his outstanding highly accomplished professional achievements in research and academic contributions. In 1995, he was elected to an F.C.P. (Fellow) from the American College of Clinical Pharmacology, New York, USA and an F.I.Biol. (Fellow) in 1997 from the Royal Institute of Biology, London, UK. This is a highly prestigious award considered to be at the level of British DSc. Prof. Sharma is an author of a book entitled “Topics in Mediators Pharmacology”, which has been published by the Nova Science Publishers Inc., N.Y., USA. Prof. Sharma is the Editor of a book Progress in Drug Research” series entitled “Recent Developments in the Regulation of Kinins” 2014 which is published by Springer Basel AG, Switzerland. He has been to numerous International conferences as invited speaker. Prof. Sharma has been holding several research grants for the support of his clinical and basic research activities and supervised PhD and MSc theses. He has been PhD external examiner and evaluator for promotions to the ranks of Associate Professor and Professor externally. In Malaysia, his research investigations were funded by the Ministry of Science and Technology, Malaysia. Currently his clinical priority research grant is funded by the Kuwait University research sector. He is the editorial board member of Pharmacy Times (USA) of Middle East from 2007 to date, Inflammopharmacology (UK) from 1997 to date, International Journal of Immunopathology and Pharmacology (Italy) from 2006 to date, European Journal of Inflammation (Italy) from 2006 to date, Archives of Medical Research (Mexico City) from 2006 to date, Clinical Medicine: Endocrinology and Diabetes (New Zealand) from 2008 to date, Clinical Medicine: Therapeutics (New Zealand) from 2009 to date, American Journal of Biomedical Sciences (USA) from 2009 to date and Journal of Pharmaceutical Technology and Drug Research (UK) from 2011 to date. He has 110 publications in reputed international biomedical journals, and 65 abstracts of national and international conferences. His work is supported by the Kuwait University Grant RP01/09.
Salva Reverentia Yurista completed his medical degree in Indonesia and he is an active practitioner in preventive cardiology with a particular interest in lipid and metabolic risk factor in Indonesia. Dr. Yurista has participated in a variety of national and international committees. He is a secretary of Malang Molecular Biology Institute and actively participates in numerous events of Indonesian Heart Foundation. He is also a member of Working Group on Atherosclerosis and Vascular Biology and Working Group on Cardiovascular Pharmacotherapy of European Society of Cardiology.
Naresh Ranjith completed his honors in microbiology and physiology at the University of Durban Westville and obtained his BSC degree in 1976. He obtained his MBChB degree at the University of Natal Medical School in 1981. Following this he completed his Doctorate in medicine [MD], the title of which was Genetic Markers in young Indian patients with Myocardial infarction, at the University of Kwa Zulu Natal in 2005. In 2006, he was awarded the FESC by the European Society of Cardiology. In 2010 he became Professor at the Nelson R Mandela School of Medicine. Currently he is Head of Cardiology at the R K Khan Hospital in Durban. He is a member of various professional bodies, some of which include the South African Heart Association, European Society of Cardiology, European Working Group on Cardiac Rehabilitation and Exercise Physiology, European Society of Acute Critical Care and European Society of Heart Failure. He is on several editorial boards, and advisory boards His research interests include the Genetics of Cardiac Disease, Cardiac Biomarkers, Heart failure and Acute Coronary Syndromes. He has published extensively in peer reviewed journals in these areas of research.
Adarsh Kumar is Professor and Head of Cardiology at GND Hospital and Medical College Amritsar since 1998 and also he is the President of International College of Cardiology. He has 25 years of cardiology teaching experience in state Medical Colleges /PGI Chandigarh and also got advanced training in America and Canada. He has published about 80 Research papers /Presentations/Guest Lectures in different International/National conferences all over the world including USA, Canada, Germany, England, Japan, Taiwan, Thailand, Pakistan and China etc. He has contributed 8 chapters in different fields of Cardiology in internationally & nationally published books. Have been awarded 11 Honorary International and National Fellowships. Recently awarded gold medal and award of excellence for outstanding contribution in the field of cardiology in the world by honorable union minister of health and family welfare at the International Heart Protection Summit September 2011.